Brooks Laboratories Limited
Incorporated in 2002, Brooks Laboratories Ltd is a pharmaceutical company working on contract basis catering to the critical care segment
What Brooks files
- Others51
- Important16
- Board Meeting9
- Updates5
- Results2
- Credit Ratings2
Brooks Laboratories established Abridge Speciality Limited as a 100% owned subsidiary, with an authorized capital of Rs. 0.01 Cr. This strategic step aims to expand the company's pharmaceutical manufacturing and marketing operations.
Brooks Steriscience Limited (BSL), a JV/associate, will not proceed with its composite scheme of arrangement and amalgamation in the current form. BSL's board has withdrawn from the previously planned merger transaction.
Brooks Steriscience (BSL) received regulatory approvals for its merger plan but will conduct a further review before court filing. This delays the scheme and introduces uncertainty for the joint venture.
BROOKS' appeals to the Income Tax Appellate Tribunal for AY 2012-13, 2014-15, and 2016-17 were dismissed, upholding prior tax additions/disallowances. The company states there is no material impact on its financials or operations.
Brooks Laboratories Limited will hold its 23rd Annual General Meeting virtually. The Annual Report for FY2024-25 is available via a weblink provided to shareholders, especially those without registered email addresses.